심정지 치료 시장 : 치료법별, 유통 채널별 - 세계 전망(2025-2030년)

The Cardiac Arrest Treatment Market was valued at USD 21.77 billion in 2023, expected to reach USD 23.73 billion in 2024, and is projected to grow at a CAGR of 9.08%, to USD 40.03 billion by 2030.

Cardiac arrest treatment encompasses emergency interventions and long-term medical care designed to restore normal heart rhythm and function following a sudden stoppage of the heart. This includes the use of automated external defibrillators (AEDs), CPR, advanced cardiac life support (ACLS), and therapeutic hypothermia. The necessity for efficient cardiac arrest treatment is underscored by the life-threatening nature of cardiac arrest and its high incidence globally. Applications range from emergency medical services to hospital settings, with significant end-use in hospitals, ambulatory surgical centers, and among first responders. The market for cardiac arrest treatment is primarily driven by rising incidences of cardiovascular diseases, growing awareness about cardiac health, advancements in medical technology, and increased accessibility to emergency medical services. Potential opportunities are proliferating in developing regions due to improving healthcare infrastructure and increasing governmental initiatives for public health education. Technological innovation, such as the development of portable AEDs with enhanced connectivity and user-friendly interfaces, presents a lucrative opportunity for market growth. However, challenges persist, such as the high cost of advanced medical devices, limited access to immediate care in remote areas, and variability in healthcare infrastructure across regions. The need for continuous education among emergency responders and bystanders to improve treatment outcomes is another critical area. Innovation in AI-driven solutions for predicting cardiac events and integrating IoT in medical devices for real-time monitoring could present paths for growth. The market is competitive and rapidly evolving, characterized by the presence of several key players investing heavily in R&D. Consolidation through acquisitions and partnerships also shapes the market landscape. Effective customer outreach and compliance with regulatory standards are recommended strategies for capturing emerging opportunities in this vital sector.

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Cardiac Arrest Treatment Market

The Cardiac Arrest Treatment Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

• Market Drivers
  • Increasing prevalence of cardiac disorders worldwide
  • Government initiatives for cardiovascular health and wellness
  • Awareness related to advancements in medical devices for the treatment of cardiac arrest
• Market Restraints
  • Expensive treatments associated with cardiac arrest
• Market Opportunities
  • Emergence of minimally invasive procedures
  • Advancements in cardiac arrest treatments and procedures
• Market Challenges
  • Lack of advanced healthcare infrastructure and skilled professionals

Porter's Five Forces: A Strategic Tool for Navigating the Cardiac Arrest Treatment Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Cardiac Arrest Treatment Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Cardiac Arrest Treatment Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Cardiac Arrest Treatment Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Cardiac Arrest Treatment Market

A detailed market share analysis in the Cardiac Arrest Treatment Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Cardiac Arrest Treatment Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Cardiac Arrest Treatment Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Cardiac Arrest Treatment Market

A strategic analysis of the Cardiac Arrest Treatment Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Cardiac Arrest Treatment Market, highlighting leading vendors and their innovative profiles. These include Abbott Laboratories, Amgen Inc., Bayer AG, BIOTRONIK SE & CO., KG, Boston Scientific Corporation, Bristol-Myers Squibb Company, Fukuda Denshi Co., Ltd, Johnson & Johnson Services, Inc., Koninklijke Philips N.V., LivaNova PLC, Medtronic PLC, Nihon Kohden Corporation, Novartis International AG, Pfizer Inc., Stryker Corporation, and ZOLL Medical Corporation.

Market Segmentation & Coverage

This research report categorizes the Cardiac Arrest Treatment Market to forecast the revenues and analyze trends in each of the following sub-markets:

• Based on Treatment, market is studied across Drug and Medical Devices. The Drug is further studied across Anti-Arrhythmic Drugs, Anticholinergic Drugs, Beta Blockers, Corticosteroids, Fibrinolytic Drugs, and Vasopressors. The Medical Devices is further studied across Cardiac Resynchronization Therapy and Defibrillators.
• Based on Distribution Channel, market is studied across Hospitals and Independent Pharmacies.
• Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

• 1.1. Objectives of the Study
• 1.2. Market Segmentation & Coverage
• 1.3. Years Considered for the Study
• 1.4. Currency & Pricing
• 1.5. Language
• 1.6. Stakeholders

2. Research Methodology

• 2.1. Define: Research Objective
• 2.2. Determine: Research Design
• 2.3. Prepare: Research Instrument
• 2.4. Collect: Data Source
• 2.5. Analyze: Data Interpretation
• 2.6. Formulate: Data Verification
• 2.7. Publish: Research Report
• 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

• 5.1. Market Dynamics
  • 5.1.1. Drivers
    • 5.1.1.1. Increasing prevalence of cardiac disorders worldwide
    • 5.1.1.2. Government initiatives for cardiovascular health and wellness
    • 5.1.1.3. Awareness related to advancements in medical devices for the treatment of cardiac arrest
  • 5.1.2. Restraints
    • 5.1.2.1. Expensive treatments associated with cardiac arrest
  • 5.1.3. Opportunities
    • 5.1.3.1. Emergence of minimally invasive procedures
    • 5.1.3.2. Advancements in cardiac arrest treatments and procedures
  • 5.1.4. Challenges
    • 5.1.4.1. Lack of advanced healthcare infrastructure and skilled professionals
• 5.2. Market Segmentation Analysis
• 5.3. Porter's Five Forces Analysis
  • 5.3.1. Threat of New Entrants
  • 5.3.2. Threat of Substitutes
  • 5.3.3. Bargaining Power of Customers
  • 5.3.4. Bargaining Power of Suppliers
  • 5.3.5. Industry Rivalry
• 5.4. PESTLE Analysis
  • 5.4.1. Political
  • 5.4.2. Economic
  • 5.4.3. Social
  • 5.4.4. Technological
  • 5.4.5. Legal
  • 5.4.6. Environmental

6. Cardiac Arrest Treatment Market, by Treatment

• 6.1. Introduction
• 6.2. Drug
  • 6.2.1. Anti-Arrhythmic Drugs
  • 6.2.2. Anticholinergic Drugs
  • 6.2.3. Beta Blockers
  • 6.2.4. Corticosteroids
  • 6.2.5. Fibrinolytic Drugs
  • 6.2.6. Vasopressors
• 6.3. Medical Devices
  • 6.3.1. Cardiac Resynchronization Therapy
  • 6.3.2. Defibrillators

7. Cardiac Arrest Treatment Market, by Distribution Channel

• 7.1. Introduction
• 7.2. Hospitals
• 7.3. Independent Pharmacies

8. Americas Cardiac Arrest Treatment Market

• 8.1. Introduction
• 8.2. Argentina
• 8.3. Brazil
• 8.4. Canada
• 8.5. Mexico
• 8.6. United States

9. Asia-Pacific Cardiac Arrest Treatment Market

• 9.1. Introduction
• 9.2. Australia
• 9.3. China
• 9.4. India
• 9.5. Indonesia
• 9.6. Japan
• 9.7. Malaysia
• 9.8. Philippines
• 9.9. Singapore
• 9.10. South Korea
• 9.11. Taiwan
• 9.12. Thailand
• 9.13. Vietnam

10. Europe, Middle East & Africa Cardiac Arrest Treatment Market

• 10.1. Introduction
• 10.2. Denmark
• 10.3. Egypt
• 10.4. Finland
• 10.5. France
• 10.6. Germany
• 10.7. Israel
• 10.8. Italy
• 10.9. Netherlands
• 10.10. Nigeria
• 10.11. Norway
• 10.12. Poland
• 10.13. Qatar
• 10.14. Russia
• 10.15. Saudi Arabia
• 10.16. South Africa
• 10.17. Spain
• 10.18. Sweden
• 10.19. Switzerland
• 10.20. Turkey
• 10.21. United Arab Emirates
• 10.22. United Kingdom

11. Competitive Landscape

• 11.1. Market Share Analysis, 2023
• 11.2. FPNV Positioning Matrix, 2023
• 11.3. Competitive Scenario Analysis
• 11.4. Strategy Analysis & Recommendation

Companies Mentioned

• 1. Abbott Laboratories
• 2. Amgen Inc.
• 3. Bayer AG
• 4. BIOTRONIK SE & CO., KG
• 5. Boston Scientific Corporation
• 6. Bristol-Myers Squibb Company
• 7. Fukuda Denshi Co., Ltd
• 8. Johnson & Johnson Services, Inc.
• 9. Koninklijke Philips N.V.
• 10. LivaNova PLC
• 11. Medtronic PLC
• 12. Nihon Kohden Corporation
• 13. Novartis International AG
• 14. Pfizer Inc.
• 15. Stryker Corporation
• 16. ZOLL Medical Corporation